Lukáš Červený

1.8k total citations
48 papers, 1.4k citations indexed

About

Lukáš Červený is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Lukáš Červený has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Pediatrics, Perinatology and Child Health and 15 papers in Infectious Diseases. Recurrent topics in Lukáš Červený's work include Drug Transport and Resistance Mechanisms (20 papers), Pregnancy and Medication Impact (14 papers) and Pharmacological Effects and Toxicity Studies (13 papers). Lukáš Červený is often cited by papers focused on Drug Transport and Resistance Mechanisms (20 papers), Pregnancy and Medication Impact (14 papers) and Pharmacological Effects and Toxicity Studies (13 papers). Lukáš Červený collaborates with scholars based in Czechia, United Kingdom and United States. Lukáš Červený's co-authors include František Štaud, Martina Čečková, Jiří Stulík, Petr Pávek, Anetta Härtlová, Radim Vrzal, Zdeněk Dvořák, Lucie Svecova, Jitka Ulrichová and Eva Anzenbacherová and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Lukáš Červený

46 papers receiving 1.4k citations

Peers

Countries citing papers authored by Lukáš Červený

Since Specialization

Citations

This map shows the geographic impact of Lukáš Červený's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukáš Červený with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukáš Červený more than expected).

Fields of papers citing papers by Lukáš Červený

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukáš Červený. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukáš Červený. The network helps show where Lukáš Červený may publish in the future.

Co-authorship network of co-authors of Lukáš Červený

This figure shows the co-authorship network connecting the top 25 collaborators of Lukáš Červený. A scholar is included among the top collaborators of Lukáš Červený based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukáš Červený. Lukáš Červený is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamic shifts in trophoblast nucleos(t)ide metabolism, transport, and adenosine signaling during gestation and preterm birth 2025 ·Scientific Reports ·Mohammed Ali, (unknown), Antonín Libra, Ivan Vokřál, Rona Karahoda, (unknown), Miroslav Lísa, (unknown), (unknown), František Štaud, Lukáš Červený	0
2	Assessment of the role of nucleoside transporters, P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in the placental transport of entecavir using in vitro, ex vivo, and in situ methods 2023 ·Toxicology and Applied Pharmacology ·Lukáš Červený, (unknown), Rona Karahoda, (unknown), (unknown), (unknown), František Štaud	2
3	Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices 2022 ·Pharmaceuticals ·(unknown), Ivan Vokřál, Ondřej Holas, (unknown), František Štaud, Lukáš Červený	3
4	Determination of Antiviral Drugs and Their Metabolites Using Micro-Solid Phase Extraction and UHPLC-MS/MS in Reversed-Phase and Hydrophilic Interaction Chromatography Modes 2021 ·Molecules ·(unknown), Maria Khalikova, Hana Vlčková, Ivona Lhotská, (unknown), Ivan Vokřál, Lukáš Červený, František Švec, Lucie Nováková	11
5	Effect of Selected Antidepressants on Placental Homeostasis of Serotonin: Maternal and Fetal Perspectives 2021 ·Pharmaceutics ·(unknown), Rona Karahoda, Lukáš Červený, (unknown), (unknown), Cilia Abad, František Štaud	22
6	Dually directional glycosylated phthalocyanines as extracellular red-emitting fluorescent probes 2020 ·Dalton Transactions ·Ali Husain, Asaithampi Ganesan, Miloslav Macháček, Lukáš Červený, Pavel Kubát, Basma Ghazal, Petr Zimčík, Saad Makhseed	4
7	Serotonin homeostasis in the materno‐foetal interface at term: Role of transporters (SERT/SLC6A4 and OCT3/SLC22A3) and monoamine oxidase A (MAO‐A) in uptake and degradation of serotonin by human and rat term placenta 2020 ·Acta Physiologica ·Rona Karahoda, (unknown), (unknown), (unknown), Lukáš Červený, Radim Kučera, Marián Kacerovský, Jurjen Duintjer Tebbens, Alexandre Bonnin, Cilia Abad, František Štaud	48
8	S-(4-Nitrobenzyl)-6-thioinosine (NBMPR) is Not a Selective Inhibitor of Equilibrative Nucleoside Transporters but Also Blocks Efflux Activity of Breast Cancer Resistance Protein 2020 ·Pharmaceutical Research ·(unknown), (unknown), (unknown), (unknown), (unknown), František Štaud, Lukáš Červený	5
9	Transport of ribavirin across the rat and human placental barrier: Roles of nucleoside and ATP-binding cassette drug efflux transporters 2019 ·Biochemical Pharmacology ·(unknown), Lukáš Červený, (unknown), Rona Karahoda, (unknown), (unknown), František Štaud	13
10	Are ENT1/ENT1, NOTCH3, and miR-21 Reliable Prognostic Biomarkers in Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Gemcitabine Monotherapy? 2019 ·Cancers ·(unknown), Aleš Ryška, Jurjen Duintjer Tebbens, Helena Hornychová, Filip Čečka, František Štaud, Lukáš Červený	6
11	Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices 2019 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), František Štaud, Filip Čečka, Ivan Vokřál, Lukáš Červený	20
12	Equilibrative Nucleoside Transporter 1 (ENT1, SLC29A1) Facilitates Transfer of the Antiretroviral Drug Abacavir across the Placenta 2018 ·Drug Metabolism and Disposition ·Lukáš Červený, (unknown), Martina Čečková, Rona Karahoda, (unknown), (unknown), Susan Greenwood, Jocelyn D. Glazier, František Štaud	25
13	Expression of Concentrative Nucleoside Transporters (SLC28A) in the Human Placenta: Effects of Gestation Age and Prototype Differentiation-Affecting Agents 2018 ·Molecular Pharmaceutics ·(unknown), Lukáš Červený, (unknown), (unknown), František Štaud	14
14	Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats 2018 ·Reproductive Toxicology ·Lukáš Červený, (unknown), (unknown), František Štaud	16
15	Role of nucleoside transporters in transplacental pharmacokinetics of nucleoside reverse transcriptase inhibitors zidovudine and emtricitabine 2017 ·Placenta ·(unknown), Lukáš Červený, (unknown), (unknown), (unknown), Susan Greenwood, František Štaud	14
16	MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption 2017 ·Antimicrobial Agents and Chemotherapy ·(unknown), Martina Čečková, (unknown), (unknown), (unknown), Lukáš Červený, František Štaud	24
17	Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta 2013 ·AIDS ·(unknown), Lukáš Červený, Martina Čečková, František Štaud	65
18	iTRAQ quantitative analysis of Francisella tularensis ssp. holarctica live vaccine strain and Francisella tularensis ssp. tularensis SCHU S4 response to different temperatures and stationary phases of growth 2009 ·PROTEOMICS ·Juraj Lenčo, Marek Link, Vojtěch Tambor, (unknown), Lukáš Červený, Jiří Stulík	25
19	Azole Antimycotics Differentially Affect Rifampicin-Induced Pregnane X Receptor-Mediated CYP3A4 Gene Expression 2007 ·Drug Metabolism and Disposition ·Lucie Svecova, Radim Vrzal, Ladislav Burýšek, Eva Anzenbacherová, Lukáš Červený, (unknown), František Trejtnar, Jiřı́ Kuneš, Milan Pour, František Štaud, Pavel Anzenbacher, Zdeněk Dvořák, Petr Pávek	50
20	Analytical Monitoring of Trinitrotoluene Metabolites in Urine by GC-MS. Part I. Semiquantitative Determination of 4-Amino-2,6-dinitrotoluene in Human Urine 2005 ·Journal of Analytical Toxicology ·Viktor Voříšek, Milan Pour, Karel Ubik, (unknown), (unknown), Lukáš Červený, Jiřı́ Kuneš, Vladimír Palička	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact